Cubist Systematic Strategies LLC Trims Position in Stericycle Inc (NASDAQ:SRCL)

Cubist Systematic Strategies LLC decreased its stake in Stericycle Inc (NASDAQ:SRCL) by 80.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,571 shares of the business services provider’s stock after selling 15,071 shares during the quarter. Cubist Systematic Strategies LLC’s holdings in Stericycle were worth $256,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. Pacer Advisors Inc. raised its position in shares of Stericycle by 8.4% during the second quarter. Pacer Advisors Inc. now owns 1,880 shares of the business services provider’s stock worth $143,000 after purchasing an additional 145 shares during the period. NEXT Financial Group Inc raised its position in Stericycle by 77.9% in the 3rd quarter. NEXT Financial Group Inc now owns 2,322 shares of the business services provider’s stock valued at $164,000 after buying an additional 1,017 shares during the last quarter. ARGI Investment Services LLC acquired a new stake in Stericycle in the 3rd quarter valued at approximately $215,000. Zions Bancorporation acquired a new stake in Stericycle in the 3rd quarter valued at approximately $233,000. Finally, Cadence Capital Management LLC acquired a new stake in Stericycle in the 3rd quarter valued at approximately $234,000. 94.49% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Stericycle Inc (NASDAQ SRCL) opened at $71.60 on Monday. The stock has a market capitalization of $6,112.70, a price-to-earnings ratio of -125.61, a P/E/G ratio of 1.74 and a beta of 0.16. Stericycle Inc has a one year low of $61.25 and a one year high of $88.00. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.93.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings results on Wednesday, November 8th. The business services provider reported $1.10 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.14 by ($0.04). The firm had revenue of $883.00 million during the quarter, compared to the consensus estimate of $896.81 million. Stericycle had a negative net margin of 0.79% and a positive return on equity of 13.93%. The business’s revenue for the quarter was down .8% compared to the same quarter last year. During the same quarter last year, the firm earned $1.24 earnings per share. equities analysts predict that Stericycle Inc will post 4.49 earnings per share for the current fiscal year.

In other Stericycle news, Director Mark C. Miller sold 19,753 shares of Stericycle stock in a transaction on Monday, November 13th. The stock was sold at an average price of $64.03, for a total value of $1,264,784.59. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders sold a total of 79,012 shares of company stock valued at $5,240,668 over the last ninety days. Insiders own 3.50% of the company’s stock.

A number of equities research analysts recently issued reports on the company. BidaskClub lowered Stericycle from a “hold” rating to a “sell” rating in a research report on Thursday. Zacks Investment Research upgraded Stericycle from a “sell” rating to a “hold” rating in a research note on Wednesday, January 10th. Barrington Research decreased their price target on Stericycle from $87.00 to $75.00 and set an “outperform” rating for the company in a research note on Friday, November 10th. Oppenheimer restated a “hold” rating on shares of Stericycle in a research note on Wednesday, December 13th. Finally, Jefferies Group set a $83.00 target price on Stericycle and gave the stock a “buy” rating in a research note on Wednesday, December 13th. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and six have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $74.45.

WARNING: This piece was originally reported by BBNS and is the sole property of of BBNS. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The legal version of this piece can be viewed at https://baseballnewssource.com/markets/cubist-systematic-strategies-llc-reduces-position-in-stericycle-inc-srcl/1816099.html.

About Stericycle

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with our FREE daily email newsletter.

 


Latest News

Houston Astros Add Starter to Rotation
Houston Astros Add Starter to Rotation
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Justin Morneau Former Star With Twins and AL MVP Retires
Justin Morneau Former Star With Twins and AL MVP Retires
MLB Rumor: Pirates Discussing Andrew McCutchen with Mets
MLB Rumor: Pirates Discussing Andrew McCutchen with Mets
Trade Rumor: Manny Machado Could Land With Yankees
Trade Rumor: Manny Machado Could Land With Yankees
Los Angeles Dodgers Acquire Scott Alexander as Part of Three Team Deal
Los Angeles Dodgers Acquire Scott Alexander as Part of Three Team Deal


Leave a Reply

 
© 2006-2018 BBNS.